Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Logothetis

Showing results (111-120 of 251) with videos related to

Pageof 26
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2016
Paired High-Content Analysis of Prostate Cancer Cells in Bone Marrow and Blood Characterizes Increased Androgen Receptor Expression in Tumor Cell ClustersAnders Carlsson, Peter Kuhn, Madelyn S Luttgen, et al.
Cell Death and Differentiation|April 13, 2026
Role of the cross-regulation between Wnt pathway activation and androgen receptor signaling in prostate cancer treatment resistanceNicolas Anselmino, Pablo Sanchis, Juan Bizzotto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
Therapy tolerance in selected patients with androgen-independent prostate cancer following strontium-89 combined with chemotherapyShi-Ming Tu, Jeri Kim, Lance C Pagliaro, et al.
Oncology Letters|April 30, 2017
Low serum testosterone is associated with tumor aggressiveness and poor prognosis in prostate cancerHuakang Tu, Jian Gu, Qing H Meng, et al.
European Urology|October 27, 2009
Morphologic characterization of preoperatively treated prostate cancer: toward a post-therapy histologic classificationEleni Efstathiou, Neil A Abrahams, Rita F Tibbs, et al.
The Prostate|June 18, 2011
Aberrant expression of katanin p60 in prostate cancer bone metastasisXiangcang Ye, Yu-Chen Lee, Michel Choueiri, et al.
European Urology|October 6, 2018
Systematic Review of Systemic Therapies and Therapeutic Combinations with Local Treatments for High-risk Localized Prostate CancerLorenzo Tosco, Alberto Briganti, Antony Vincent D'amico, et al.
BMC Cancer|November 4, 2010
Prioritizing genes associated with prostate cancer developmentIvan P Gorlov, Kanishka Sircar, Hongya Zhao, et al.
Scientific Reports|October 18, 2016
Targeting of CYP17A1 Lyase by VT-464 Inhibits Adrenal and Intratumoral Androgen Biosynthesis and Tumor Growth of Castration Resistant Prostate CancerSankar N Maity, Mark A Titus, Revekka Gyftaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2010
Preoperative CTLA-4 blockade: tolerability and immune monitoring in the setting of a presurgical clinical trialBradley C Carthon, Jedd D Wolchok, Jianda Yuan, et al.
Pageof 26

Showing results (111-120 of 251) with videos related to

Sort By:
Pageof 26
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2016
Paired High-Content Analysis of Prostate Cancer Cells in Bone Marrow and Blood Characterizes Increased Androgen Receptor Expression in Tumor Cell ClustersAnders Carlsson, Peter Kuhn, Madelyn S Luttgen, et al.
Cell Death and Differentiation|April 13, 2026
Role of the cross-regulation between Wnt pathway activation and androgen receptor signaling in prostate cancer treatment resistanceNicolas Anselmino, Pablo Sanchis, Juan Bizzotto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
Therapy tolerance in selected patients with androgen-independent prostate cancer following strontium-89 combined with chemotherapyShi-Ming Tu, Jeri Kim, Lance C Pagliaro, et al.
Oncology Letters|April 30, 2017
Low serum testosterone is associated with tumor aggressiveness and poor prognosis in prostate cancerHuakang Tu, Jian Gu, Qing H Meng, et al.
European Urology|October 27, 2009
Morphologic characterization of preoperatively treated prostate cancer: toward a post-therapy histologic classificationEleni Efstathiou, Neil A Abrahams, Rita F Tibbs, et al.
The Prostate|June 18, 2011
Aberrant expression of katanin p60 in prostate cancer bone metastasisXiangcang Ye, Yu-Chen Lee, Michel Choueiri, et al.
European Urology|October 6, 2018
Systematic Review of Systemic Therapies and Therapeutic Combinations with Local Treatments for High-risk Localized Prostate CancerLorenzo Tosco, Alberto Briganti, Antony Vincent D'amico, et al.
BMC Cancer|November 4, 2010
Prioritizing genes associated with prostate cancer developmentIvan P Gorlov, Kanishka Sircar, Hongya Zhao, et al.
Scientific Reports|October 18, 2016
Targeting of CYP17A1 Lyase by VT-464 Inhibits Adrenal and Intratumoral Androgen Biosynthesis and Tumor Growth of Castration Resistant Prostate CancerSankar N Maity, Mark A Titus, Revekka Gyftaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2010
Preoperative CTLA-4 blockade: tolerability and immune monitoring in the setting of a presurgical clinical trialBradley C Carthon, Jedd D Wolchok, Jianda Yuan, et al.
Pageof 26